共 50 条
- [1] COMBINATION CHEMOTHERAPY IN SMALL CELL LUNG-CANCER (SCLC) PATIENTS WITH CARDIOMYOPATHY [J]. CLINICAL RESEARCH, 1985, 33 (01): : A73 - A73
- [2] THYMOSIN FRACTION V PROLONGS SURVIVAL OF SMALL CELL LUNG-CANCER (SCLC) PATIENTS TREATED WITH INTENSIVE COMBINATION CHEMOTHERAPY [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 117 - 117
- [3] MENINGEAL CARCINOMATOSIS (MC) FOLLOWING INTENSIVE COMBINATION CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER (SCLC) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 187 - 187
- [5] COMPLETE RESPONSES OBTAINED BY INTENSIVE CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) [J]. BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S116 - S116
- [6] SEQUENTIAL ALTERNATING COMBINATION CHEMOTHERAPY + RADIOTHERAPY IN SMALL CELL LUNG-CANCER (SCLC) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 177 - 177
- [8] INTENSIVE ALTERNATING COMBINATION CHEMOTHERAPY OF SMALL CELL ANAPLASTIC LUNG-CANCER [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 377 - 377
- [9] THYMOSIN FRACTION-V AND INTENSIVE COMBINATION CHEMOTHERAPY - PROLONGING THE SURVIVAL OF PATIENTS WITH SMALL-CELL LUNG-CANCER [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (17): : 1813 - 1815